Table 4.

Multivariable models for factors associated withsingle- and multiple-type HPV by oncogenicity, HPV Detection in Men study

	Oncogenic		Nononcogenic
	Multiple types,* OR (95% CI)	Single type,* OR (95% CI)	Multiple types,* OR (95% CI)	Single type,* OR (95% CI)
Age (y)
18-19	Reference	Reference	Reference	Reference
20-24	0.55 (0.16-1.85)	1.47 (0.46-4.78)	1.14 (0.31-4.12)	0.89 (0.35-2.28)
25-29	0.47 (0.12-1.81)	1.65 (0.48-5.63)	1.18 (0.30-4.61)	1.08 (0.39-2.93)
30-34	0.29 (0.06-1.36)	1.02 (0.27-3.82)	0.25 (0.05-1.24)	0.47 (0.16-1.43)
35-40	0.29 (0.06-1.29)	1.00 (0.27-3.70)	0.13 (0.02-0.74)	0.56 (0.19-1.68)
Ethnicity
Non-Hispanic White	Reference	Reference	Reference	Reference
Hispanic	2.71 (1.17-6.32)	1.73 (0.88-3.44)	2.44 (1.03-5.79)	3.25 (1.69-6.26)
Currently smokes (cigarettes/d)
<10	Reference	Reference	Reference	Reference
≥10	1.86 (0.62-5.58)	1.33 (0.57-3.10)	2.35 (0.80-6.95)	3.34 (1.45-7.71)
Lifetime no. female partners
1-5	Reference	Reference	Reference	Reference
6-10	1.61 (0.51-5.08)	2.03 (0.90-4.57)	4.35 (1.33-14.2)	3.50 (1.71-7.18)
11-20	2.78 (0.96-8.10)	2.81 (1.29-6.14)	8.65 (2.82-26.5)	3.66 (1.78-7.52)
≥21	4.62 (1.59-13.4)	4.48 (2.03-9.90)	22.89 (7.43-70.5)	3.49 (1.57-7.74)
Condom use during vaginal sex in the past 3 mo
At least half the time	Reference	Reference	Reference	Reference
Less than half the time	2.52 (1.12-5.71)	2.34 (1.31-4.17)	1.45 (0.72-2.91)	1.74 (1.01-2.99)
Warts detected at clinical visit	5.54 (1.26-24.3)	2.86 (0.74-11.0)	11.94 (1.84-77.7)	7.07 (1.28-39.0)

NOTE: ORs are adjusted for all other variables in the table.

^*Using multinomial logistic regression, “no HPV” is the base outcome category.